About
Talus Bio develops a proprietary platform that unlocks the regulome in live cells to identify and modulate drug targets involved in gene regulation, focusing on discovering new therapeutics for oncology, rare diseases, and immune dysfunction.
Explore Talus Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.